Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Sorrento Therapeutics Inc
SRNE | US
0.00
USD0.00
15.15%
SRNE | US
About Sorrento Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2023
As of date
13/03/2026
Close
0.00
Open
0.00
High
0.01
Low
0.00
View Less
SRNE | US
Risk
957.4
Sharpe
0.38
Luna's Score
49/100
Recommendation
Hold
Luna says (SRNE | US)
What's Working
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
824.8%1 month
957.4%3 months
745.9%6 months
566.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
1.18
Price to book
4.01
Debt to equity
-1.01
Debt to assets
0.45
Ent. to EBITDA
-0.25
Ent. to rev.
2.00
PEG
-0.07
Other Fundamentals
EBITDA
-341.59M
MarketCap
2.41M
MarketCap(USD)
2.41M
Div. yield
-
Op. margin
-510.93
Erngs. growth
-
Rev. growth
31.10
Ret. on equity
-378.92
Short ratio
4.96
Short perc.
11.96
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.00
Range1M
0.01
Range3M
0.01
Volumes: Market Activity
Rel. volume
0.31
Price X volume
110.23
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.25 | - | Cheaper |
| Ent. to Revenue | 2.00 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.01 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 745.86 | - | Riskier |
| Debt to Equity | -1.01 | -1.23 | Cheaper |
| Debt to Assets | 0.45 | 0.25 | Expensive |
| Market Cap | 2.41M | - | Emerging |
